Product Description
The global cervical fixation market was valued at over $1.9 billion in 2024. This is expected to increase over the forecast period at a CAGR of 4.1% to reach nearly $2.6 billion.
The full report suite on the global market for cervical fixation includes anterior and posterior cervical fixation subsegments.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL CERVICAL FIXATION MARKET TRENDS
One major driver of this market is the technological improvements to cervical fixation devices, including improved anterior fixation technologies and innovative posterior fixation techniques, both of which will slow the decline in ASPs and increase the market’s size. Improvements in design for dynamic and bioresorbable plates account for the bulk of technological improvement for cervical fixation devices.
GLOBAL CERVICAL FIXATION MARKET SHARE INSIGHT
- Medtronic was the leader of the global cervical fixation market in 2024. Medtronic had the strongest presence in North America and Asia-Pacific and the lowest shares in Latin America. In 2007, Medtronic was forced to discontinue its Vertex® posterior screw/rod system after a jury determined that the company had infringed upon a patent for polyaxial screw technology licensed to DePuy Spine. As a result, Medtronic lost its former leading market share in the posterior cervical fixation market. However, Medtronic later released its Vertex Select Reconstruction System, allowing the company to regain the leading posterior market position.
- DePuy Synthes was the second-leading competitor in the global cervical fixation market in 2024. In terms of posterior cervical fixation devices, DePuy Synthes offers several wiring and cable systems, including Songer® cable systems. The Summit™ SI OCT system is an occipitocervical fixation system that includes an occipital plate and long rods for screws, which can be extended to the thoracic region of the spine. The Summit™ SI OCT system is primarily intended for fusion from the T1-T3 vertebrae, making it an occipito-cervico-thoracic fixation device. The Summit™, MOUNTAINEER™ OCT spinal systems and Axon® system contributed to the company’s revenue in the posterior cervical fixation market.
- Globus Medical/NuVasive the combined entity emerged as the third-leading competitor in the global cervical fixation market in 2024. The integration of NuVasive’s strong presence in the posterior cervical segment with Globus’ robust implant portfolio has expanded their reach across multiple geographies. Globus’ products, such as the REFLECT® and QUARTEX® OCT systems, complement NuVasive’s Reline® OCT and Helix® systems, allowing the merged company to offer a comprehensive suite of occipital-cervico-thoracic solutions. The combined product breadth, global sales infrastructure and increased surgeon engagement have positioned Globus Medical/NuVasive to compete more effectively with market leaders in both the posterior and anterior cervical fixation markets.
MARKET SEGMENTATION SUMMARY
- Anterior Market
- Posterior Market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
